vs

Side-by-side financial comparison of Carter Bankshares, Inc. (CARE) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

Neuronetics, Inc. is the larger business by last-quarter revenue ($41.8M vs $39.8M, roughly 1.0× Carter Bankshares, Inc.). On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs 15.4%). Carter Bankshares, Inc. produced more free cash flow last quarter ($31.8M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs 9.1%).

Carter Bankshares, Inc. is a U.S. regional bank holding company operating Carter Bank & Trust, a community-focused financial institution. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, and wealth management services, primarily serving consumers and small business clients across Virginia and North Carolina.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

CARE vs STIM — Head-to-Head

Bigger by revenue
STIM
STIM
1.0× larger
STIM
$41.8M
$39.8M
CARE
Growing faster (revenue YoY)
STIM
STIM
+70.3% gap
STIM
85.7%
15.4%
CARE
More free cash flow
CARE
CARE
$31.1M more FCF
CARE
$31.8M
$692.0K
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
9.1%
CARE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CARE
CARE
STIM
STIM
Revenue
$39.8M
$41.8M
Net Profit
$-7.2M
Gross Margin
52.0%
Operating Margin
27.8%
-12.1%
Net Margin
-17.2%
Revenue YoY
15.4%
85.7%
Net Profit YoY
43.2%
EPS (diluted)
$0.38
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CARE
CARE
STIM
STIM
Q4 25
$39.8M
$41.8M
Q3 25
$39.1M
$37.3M
Q2 25
$37.3M
$38.1M
Q1 25
$37.0M
$32.0M
Q4 24
$34.5M
$22.5M
Q3 24
$34.2M
$18.5M
Q2 24
$33.6M
$16.4M
Q1 24
$33.5M
$17.4M
Net Profit
CARE
CARE
STIM
STIM
Q4 25
$-7.2M
Q3 25
$5.4M
$-9.0M
Q2 25
$8.5M
$-10.1M
Q1 25
$9.0M
$-12.7M
Q4 24
$-12.7M
Q3 24
$5.6M
$-13.3M
Q2 24
$4.8M
$-9.8M
Q1 24
$5.8M
$-7.9M
Gross Margin
CARE
CARE
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
CARE
CARE
STIM
STIM
Q4 25
27.8%
-12.1%
Q3 25
18.3%
-19.6%
Q2 25
28.5%
-21.1%
Q1 25
30.1%
-34.4%
Q4 24
31.0%
-51.0%
Q3 24
20.5%
-41.7%
Q2 24
17.6%
-51.7%
Q1 24
21.6%
-39.4%
Net Margin
CARE
CARE
STIM
STIM
Q4 25
-17.2%
Q3 25
13.9%
-24.3%
Q2 25
22.8%
-26.6%
Q1 25
24.2%
-39.6%
Q4 24
-56.4%
Q3 24
16.4%
-72.0%
Q2 24
14.3%
-59.8%
Q1 24
17.4%
-45.2%
EPS (diluted)
CARE
CARE
STIM
STIM
Q4 25
$0.38
$-0.10
Q3 25
$0.24
$-0.13
Q2 25
$0.37
$-0.15
Q1 25
$0.39
$-0.21
Q4 24
$0.36
$-0.34
Q3 24
$0.24
$-0.44
Q2 24
$0.21
$-0.33
Q1 24
$0.25
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CARE
CARE
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$28.1M
Total DebtLower is stronger
$65.8M
Stockholders' EquityBook value
$419.7M
$22.4M
Total Assets
$4.9B
$141.6M
Debt / EquityLower = less leverage
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CARE
CARE
STIM
STIM
Q4 25
$28.1M
Q3 25
$28.0M
Q2 25
$11.0M
Q1 25
$20.2M
Q4 24
$18.5M
Q3 24
$20.9M
Q2 24
$42.6M
Q1 24
$47.7M
Total Debt
CARE
CARE
STIM
STIM
Q4 25
$65.8M
Q3 25
$65.7M
Q2 25
$55.5M
Q1 25
$55.3M
Q4 24
$55.2M
Q3 24
$46.0M
Q2 24
$59.8M
Q1 24
$59.4M
Stockholders' Equity
CARE
CARE
STIM
STIM
Q4 25
$419.7M
$22.4M
Q3 25
$412.8M
$27.4M
Q2 25
$405.6M
$27.1M
Q1 25
$401.8M
$35.5M
Q4 24
$384.3M
$27.7M
Q3 24
$386.8M
$9.4M
Q2 24
$364.4M
$19.4M
Q1 24
$359.1M
$27.7M
Total Assets
CARE
CARE
STIM
STIM
Q4 25
$4.9B
$141.6M
Q3 25
$4.8B
$145.5M
Q2 25
$4.8B
$134.7M
Q1 25
$4.7B
$142.0M
Q4 24
$4.7B
$140.9M
Q3 24
$4.6B
Q2 24
$4.5B
$96.8M
Q1 24
$4.6B
$103.8M
Debt / Equity
CARE
CARE
STIM
STIM
Q4 25
2.94×
Q3 25
2.40×
Q2 25
2.05×
Q1 25
1.56×
Q4 24
1.99×
Q3 24
4.90×
Q2 24
3.08×
Q1 24
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CARE
CARE
STIM
STIM
Operating Cash FlowLast quarter
$39.9M
$908.0K
Free Cash FlowOCF − Capex
$31.8M
$692.0K
FCF MarginFCF / Revenue
79.9%
1.7%
Capex IntensityCapex / Revenue
20.2%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$54.6M
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CARE
CARE
STIM
STIM
Q4 25
$39.9M
$908.0K
Q3 25
$11.8M
$-785.0K
Q2 25
$9.6M
$-3.5M
Q1 25
$6.4M
$-17.0M
Q4 24
$36.9M
$-8.6M
Q3 24
$10.3M
$-5.4M
Q2 24
$-2.5M
$-5.0M
Q1 24
$17.6M
$-12.0M
Free Cash Flow
CARE
CARE
STIM
STIM
Q4 25
$31.8M
$692.0K
Q3 25
$10.3M
$-899.0K
Q2 25
$7.7M
$-3.8M
Q1 25
$4.9M
$-17.2M
Q4 24
$28.8M
$-8.7M
Q3 24
$8.4M
$-5.8M
Q2 24
$-4.3M
$-5.6M
Q1 24
$16.3M
$-12.4M
FCF Margin
CARE
CARE
STIM
STIM
Q4 25
79.9%
1.7%
Q3 25
26.3%
-2.4%
Q2 25
20.6%
-9.9%
Q1 25
13.1%
-53.8%
Q4 24
83.5%
-38.6%
Q3 24
24.6%
-31.3%
Q2 24
-12.7%
-34.0%
Q1 24
48.8%
-71.1%
Capex Intensity
CARE
CARE
STIM
STIM
Q4 25
20.2%
0.5%
Q3 25
3.9%
0.3%
Q2 25
5.1%
0.7%
Q1 25
4.1%
0.7%
Q4 24
23.6%
0.4%
Q3 24
5.5%
2.1%
Q2 24
5.4%
3.7%
Q1 24
3.9%
2.2%
Cash Conversion
CARE
CARE
STIM
STIM
Q4 25
Q3 25
2.18×
Q2 25
1.13×
Q1 25
0.71×
Q4 24
Q3 24
1.83×
Q2 24
-0.51×
Q1 24
3.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons